Biomerica adds Harry Leider, MD, MBA to Strategic Advisory Board
April 19, 2018 08:19 ET
|
Biomerica, Inc.
IRVINE, Calif., April 19, 2018 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq:BMRA) today announced that it has added Harry L. Leider, MD, MBA to its Strategic Advisor Board, which is chaired by Edward...
Biomerica Announces Third Quarter Financial Results
April 17, 2018 09:00 ET
|
Biomerica, Inc.
IRVINE, Calif., April 17, 2018 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq:BMRA) today reported net sales of $4,433,785 for the nine months ending February 28, 2018, compared to $4,342,247 for the...
Mexico’s COFEPRIS (Mexico’s equivalent of the FDA) approves Biomerica colorectal screening test to help identify the early warning signs of colorectal cancer
March 08, 2018 08:19 ET
|
Biomerica, Inc.
IRVINE, Calif., March 08, 2018 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq:BMRA) announced the Mexico’s COFEPRIS (Comisión Federal para la Protección contra Riesgos Sanitarios - Mexico’s equivalent...
Biomerica Announces Second Quarter Financial Results; Sales Up 12.7% for the Quarter
January 16, 2018 09:18 ET
|
Biomerica, Inc.
IRVINE, Calif., Jan. 16, 2018 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq:BMRA) today reported net sales of $1,613,636 for the three months ended November 30, 2017, compared to $1,432,206 for the...
China Food and Drug Administration (CFDA) approves Biomerica colorectal screening test to help identify the early warning signs of colorectal cancer
January 10, 2018 08:19 ET
|
Biomerica, Inc.
IRVINE, Calif., Jan. 10, 2018 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq:BMRA) announced the China Food and Drug Administration (CFDA) approval of the EZ Detect™ colorectal screening test designed...
Biomerica Signs Agreements with Beth Israel Deaconess & University of Michigan to Initiate Clinical Study for First of a Kind, Irritable Bowel Syndrome (IBS) Diagnostic Guided Therapy (DGT)
January 08, 2018 08:19 ET
|
Biomerica, Inc.
- DGT Designed to identify patient specific foods, that when removed, may alleviate an individual's IBS symptoms - DGT can be used alongside current IBS drug treatments to potentially improve...
Biomerica Extends Exclusive License Agreement with Celtis Pharm (Telcon Pharmaceuticals) to December 2019
November 07, 2017 08:19 ET
|
Biomerica, Inc.
IRVINE, Calif., Nov. 07, 2017 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ:BMRA) today announced that it has extended its exclusive license agreement with Celtis Pharm Co. Ltd of South Korea. Celtis...
Biomerica Reports 1st Quarter Fiscal 2018 Financials
October 17, 2017 08:19 ET
|
Biomerica, Inc.
IRVINE, Calif., Oct. 17, 2017 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq:BMRA) today reported net sales of $1,444,483 for the three months ending August 31, 2017, compared to $1,410,110 for the...
Biomerica Commences Clinical Studies for New Gastroenterology H. Pylori Test
September 12, 2017 08:19 ET
|
Biomerica, Inc.
IRVINE, Calif., Sept. 12, 2017 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ:BMRA) today announced that the Company has commenced clinical studies to evaluate the performance of its new and proprietary...
Biomerica Announces Fiscal Year End 2017 Financial Results; Sales Up 12.7% for the year
August 30, 2017 08:19 ET
|
Biomerica, Inc.
IRVINE, Calif., Aug. 30, 2017 (GLOBE NEWSWIRE) -- Biomerica, Inc. (Nasdaq:BMRA), a global provider of advanced diagnostic products, today reported net sales for the fiscal year 2017 were $5,791,670...